Re PTLA Dew ..Dec 19th Bristol- Meyers and Pfizer signed a $50m loan agreement with them . This loan is non-secured and does not involve any transfer of patent ownership or licenses . No shares , options , warrants etc will be issued in connection with this loan .
Repayment of loan is primarily thru royalties on commercial sales . They ( BM and Pfizer ) appear to be betting on approval for some indications ?
Since I’m skeptical of the approval chances of this NDA (for reasons previously mentioned on this board), I’m inclined to interpret the lack of an advisory panel as more bearish than bullish.
Market Data 
Markets 
AI
